69 related articles for article (PubMed ID: 1879084)
1. Calcium influx into red blood cells: the effect of sera from patients with systemic sclerosis.
Rademaker M; Thomas RH; Kirby JD; Kovacs IB
Clin Exp Rheumatol; 1991; 9(3):247-51. PubMed ID: 1879084
[TBL] [Abstract][Full Text] [Related]
2. Abnormal effect of sera from patients with atherosclerosis on calcium influx into normal erythrocytes.
Jendryczko A; Pardela M
Cor Vasa; 1992; 34(5-6):428-33. PubMed ID: 1339714
[TBL] [Abstract][Full Text] [Related]
3. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
[TBL] [Abstract][Full Text] [Related]
4. Altered behaviour of erythrocytes in scleroderma.
Kovacs IB; Sowemimo-Coker SO; Kirby JD; Turner P
Clin Sci (Lond); 1983 Nov; 65(5):515-9. PubMed ID: 6617097
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis.
Dowd PM; Kovacs IB; Bland CJ; Kirby JD
Br Med J (Clin Res Ed); 1981 Aug; 283(6287):350. PubMed ID: 6788326
[No Abstract] [Full Text] [Related]
6. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
Seibold JR; Harris JN
J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
[TBL] [Abstract][Full Text] [Related]
7. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.
Pancera P; Sansone S; Presciuttini B; Montagna L; Cerù S; Lunardi C; Lechi A
Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106
[TBL] [Abstract][Full Text] [Related]
8. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous neutrophil activation in patients with primary Raynaud's phenomenon and systemic sclerosis.
Stevens TR; Hall ND; McHugh NJ; Maddison PJ
Br J Rheumatol; 1992 Dec; 31(12):856. PubMed ID: 1458295
[No Abstract] [Full Text] [Related]
10. Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynauds syndrome.
Belch JJ; McLaren M; Anderson J; Lowe GD; Sturrock RD; Capell HA; Forbes CD
Prostaglandins Leukot Med; 1985 Jan; 17(1):1-9. PubMed ID: 3883365
[TBL] [Abstract][Full Text] [Related]
11. Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome.
Belch JJ; McLaren M; Anderson J; Lowe GD; Sturrock RD; Capell HA; Forbes CD; Mikhailidis DP; Jeremy JY; Dandona P
Prostaglandins Leukot Med; 1985 Jun; 18(3):401-2. PubMed ID: 3895252
[No Abstract] [Full Text] [Related]
12. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
13. [Rheology of giant capillary occlusion in secondary Raynaud's phenomenon within the scope of systemic sclerosis].
Schmid-Schönbein H; Goebel W; Perkkiö J; Polster H; Jacobs M; Lemmens HA
Vasa Suppl; 1989; 27():61-3. PubMed ID: 2623545
[No Abstract] [Full Text] [Related]
14. [Erythrocyte filterability in Raynaud's disease].
Sciannameo F; Francucci M; Cao PG; Marianeschi P; Valentini M; Tockner M; Sassano L; Grasselli A
Ric Clin Lab; 1983; 13 Suppl 3():475-80. PubMed ID: 6673030
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell alterations in systemic sclerosis: a pilot study.
Giovannetti A; Gambardella L; Pietraforte D; Rosato E; Giammarioli AM; Salsano F; Malorni W; Straface E
Cell Physiol Biochem; 2012; 30(2):418-27. PubMed ID: 22814239
[TBL] [Abstract][Full Text] [Related]
16. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 and cold provocation in health, primary Raynaud's phenomenon, and progressive systemic sclerosis.
Dörffler-Melly J; Lüscher TF; Wenk M; Wen S; Bollinger A; Franzeck UK
Microvasc Res; 1996 Sep; 52(2):193-7. PubMed ID: 8901448
[No Abstract] [Full Text] [Related]
18. Euthyroid sick syndrome and inhibitory effect of sera on the activity of thyroid 5'-deiodinase in systemic sclerosis.
Molnár I; Czirják L
Clin Exp Rheumatol; 2000; 18(6):719-24. PubMed ID: 11138334
[TBL] [Abstract][Full Text] [Related]
19. [Decreased blood fluidity in progressive systemic scleroderma].
Ernst E; Lohmaier EF; Meurer M; Gerstmeier J
Z Rheumatol; 1990; 49(3):155-9. PubMed ID: 2378174
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
